Eribulin acts as an immune adjuvant to enhance the antitumor efficacy of STING agonists in triple-negative breast cancer models

被引：0
|
作者：
Takahashi-Ruiz, Leila
Fermaintt, Charles S.
Wilkinson, Nancy
Chan, Peter Y.
Mooberry, Susan L.
Risinger, April L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6397
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
    Takahashi-Ruiz, Leila
    Fermaintt, Charles S.
    Wilkinson, Nancy J.
    Chan, Peter Y. W.
    Mooberry, Susan L.
    Risinger, April L.
    CANCERS, 2022, 14 (23)
  • [2] Eribulin Enhances Interferon Production by STING Agonists in Models of Triple-Negative Breast Cancer
    Takahashi-Ruiz, Leila
    Fermaintt, Charles S.
    Chan, Peter Y.
    Liang, Hui
    Mooberry, Susan L.
    Risinger, April L.
    FASEB JOURNAL, 2022, 36
  • [3] Eribulin enhances STING-dependent induction of type I interferons in immune and triple-negative breast cancer cells
    Takahashi-Ruiz, Leila
    Fermaintt, Charles
    Wilkinson, Nancy
    Mooberry, Susan
    Risinger, April
    CANCER RESEARCH, 2023, 83 (05)
  • [4] TAK228 enhances antitumor activity of eribulin in triple-negative breast cancer
    Owusu-Brackett, Nicci
    Evans, Kurt W.
    Akcakanat, Argun
    Yuca, Erkan
    Dumbrava, Ecaterina Ileana
    Janku, Filip
    Meric-Bernstam, Funda
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 45 - 45
  • [5] Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
    Xi, Xun
    Huang, Xingwei
    Yuan, Huozhong
    Ni, Jun
    Yang, Fulan
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [6] Preclinical analysis of synergistic antitumor effect of eribulin and HDAC inhibitor for triple-negative breast cancer cells
    Oba, Takaaki
    Izumi, Hiroto
    Ito, Ken-ichi
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Antitumor activity of new antibody-drug conjugate with eribulin in triple-negative breast cancer PDX
    de Boisferon, Marc Hillairet
    Mignard, Caroline
    Durix, Coralie
    Uenaka, Toshimitsu
    Rybinski, Katherine
    Cheng, Xin
    Furuuchi, Keiji
    Albone, Eart
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [8] Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models
    Pogorzelska, A.
    Switalska, M.
    Wietrzyk, J.
    Mazur, M.
    Milczarek, M.
    Medynska, K.
    Wiktorska, K.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [9] Experience with eribulin in triple-negative metastatic breast cancer: case studies
    Gallegos Sancho, Maria Isabel
    Marquez-Vazquez, Raul
    Sanchez-Munoz, Alfonso
    FUTURE ONCOLOGY, 2018, 14 (07) : 13 - 20
  • [10] The advance of adjuvant treatment for triple-negative breast cancer
    Ge, Jingyu
    Zuo, Wenjia
    Chen, Yiyu
    Shao, Zhiming
    Yu, Keda
    CANCER BIOLOGY & MEDICINE, 2022, 19 (02) : 187 - 201
12345